광견병 수의용 백신 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Rabies Veterinary Vaccines Market size is expected to reach USD 1.48 Billion in 2034 from USD 0.85 Billion (2025) growing at a CAGR of 6.37% during 2026-2034.

The Global Rabies Veterinary Vaccines Market is expanding as awareness about animal health and zoonotic diseases continues to increase. Rabies remains a serious viral disease affecting pets and livestock, especially in developing regions. Governments and animal welfare organizations are promoting vaccination programs to control and eliminate rabies transmission among animals and humans.

Major drivers include mandatory vaccination regulations for companion animals and rising pet ownership worldwide. Increasing livestock populations and initiatives to improve veterinary healthcare infrastructure are also supporting market growth. Advances in vaccine formulations and cold chain distribution systems have improved accessibility and effectiveness.

Future prospects appear promising as global campaigns aim to eliminate dog-mediated rabies. Public-private partnerships and international health programs are expected to strengthen vaccination coverage in rural and underserved areas. Continuous research and development efforts may result in longer-lasting and more cost-effective vaccines, boosting overall adoption rates.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

• Companion Animals
• Livestock Animals
• Wildlife Animals

By Distribution Channel

• Retail
• E-Commerce
• Hospital/Clinic Pharmacies

COMPANIES PROFILED

• Boehringer Ingelheim International GmbH, Zoetis Services LLC, Merck Co Inc, Elanco, BroadChem Philippines Biopharma Corporation, Virbac, Ceva, BiognesisBag, Indian Immunologicals Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL RABIES VETERINARY VACCINES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Application
• 4.2. Companion Animals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Livestock Animals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Wildlife Animals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL RABIES VETERINARY VACCINES MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Distribution Channel
• 5.2. Retail Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. E-Commerce Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Hospital/Clinic Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL RABIES VETERINARY VACCINES MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Application
  • 6.2.2 By Distribution Channel
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Application
  • 6.3.2 By Distribution Channel
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Application
  • 6.4.2 By Distribution Channel
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Application
  • 6.5.2 By Distribution Channel
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Application
  • 6.6.2 By Distribution Channel
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL RABIES VETERINARY VACCINES INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Boehringer Ingelheim International GmbH
  • 8.2.2 Zoetis Services LLC
  • 8.2.3 Merck & Co. Inc
  • 8.2.4 Elanco
  • 8.2.5 BroadChem Philippines Biopharma Corporation
  • 8.2.6 Virbac
  • 8.2.7 Ceva
  • 8.2.8 BiogAfA(C)NesisBagAfA3
  • 8.2.9 Indian Immunologicals Ltd